Guoxin Kechuang Fund Management
China Reform Fund is a private equity firm that focuses on investments in technology and medical device industries.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Guoxin Kechuang Fund Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
8,719,953Website Global Rank
271Website Monthly Traffic
Twitter Followers
Description
China Reform Fund is a private equity firm that focuses on investments in technology and medical device industries.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2018 | Bairong | Series C | 0 |
| 4/2020 | MicroPort CardioFlow | Private Equity Round | 130M |
| 1/2020 | Teld New Energy | Series A | 0 |
| 4/2018 | Manbang Group | Private Equity Round | 0 |
| 12/2021 | DERA | Series C | - |
| 12/2018 | 4Paradigm | Series C | 0 |
| 11/2017 | 3D Medicines | Private Equity Round | 0 |
| 11/2019 | Ucaidao | Venture Round | 0 |
| 3/2020 | Remegen | Private Equity Round | 0 |
| 10/2018 | CloudWalk Technology | Series B | 0 |
| 12/2021 | DERA | Series C | - |
| 4/2020 | MicroPort CardioFlow | Private Equity Round | 0 |
| 3/2020 | Remegen | Private Equity Round | 0 |
| 1/2020 | Teld New Energy | Series A | 0 |
| 11/2019 | Ucaidao | Venture Round | 0 |
| 12/2018 | 4Paradigm | Series C | 0 |
| 10/2018 | CloudWalk Technology | Series B | 0 |
| 4/2018 | Manbang Group | Private Equity Round | 0 |
| 4/2018 | Bairong | Series C | 0 |
| 11/2017 | 3D Medicines | Private Equity Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
